Elevated Risk of Asthma Among Proton Pump Inhibitor Users: Evidence From Meta-Analysis

Abstract

Get full access to this article

View all access options for this article.

References

Wang

Wintzell

Ludvigsson

, et al Association between proton pump inhibitor use and risk of asthma in children. JAMA Pediatr. 2021;175(4):394-403. doi:10.1001/jamapediatrics.2020.5710

Wang

Yang

Associations between proton-pump inhibitor usage, allergy, and asthma: an analysis of NHANES 2005-2006. Int Arch Allergy Immunol. 2024;185(6):519-526. doi:10.1159/000535156

Choi

Min

Yoo

, et al Associations between asthma diagnosis/asthma exacerbation and previous proton-pump inhibitor use: a nested case-control study using a national health screening cohort. Front Pharmacol. 2022;13:888610. doi:10.3389/fphar.2022.888610

SAH

Abdi

Shukla

Khan

Al Zahrani

. Hepatotoxicity is the risk factor with gemtuzumab ozogamicin treatment in acute myelogenous leukaemia patients. Clin Res Hepatol Gastroenterol. 2021;45(6):101443. doi:10.1016/j.clinre.2020.04.013

Lim

Noh

, et al Association between proton pump inhibitors use and risk of asthma in Korea: a prevalent new-user cohort study. Medicine (Baltimore). 2024;5103(1):1031. doi:10.1097/md.0000000000036772

Wang

Zhou

Zhang

, et al Pathogenesis of allergic diseases and implications for therapeutic interventions. Signal Transduct Target Ther. 2023;8:138. doi:10.1038/s41392-023-01344-4

Kiecka

Szczepanik

Proton pump inhibitor-induced gut dysbiosis and immunomodulation: current knowledge and potential restoration by probiotics. Pharmacol Rep. 2023;75(4):791-804. doi:10.1007/s43440-023-00489-x

Wang

Tsai

Wang

Wei

JC.

Association between proton pump inhibitors and asthma: a population-based cohort study. Front Pharmacol. 2020;11:607. doi:10.3389/fphar.2020.00607

Wang

Chang

, et al Proton-pump inhibitors are associated with an increased risk of asthma: a nationwide nested case-control study. Allergy Asthma Proc. 2023;44:345-353. doi:10.2500/aap.2023.44.230035

10.

Lin

Tsai

Huang

, et al Exposure to proton pump inhibitors and the risk of incident asthma in patients with coronary artery diseases: a population-based cohort study. J Pers Med. 2022;12:824. doi:10.3390/jpm12050824